TALEN
| Source | Web search geneticliteracyproject.org/2018/05/15/usdas-hands-off-app… |
|---|---|
| Organization | Cellectis |
| Market status | On the market |
| Industry | Health + Multipurpose |
| Value chain stage | Platform |
| Intended consumer | Research |
| Production process | Closed Production |
| Business models | B2B |
| Product categories | Research |
| Biotech components | Molecule |
| Organization type(s) | Public Company |
| Funding types | Shareholder Investment |
| Known funding amount | € 17,400,000 EUR |
| Country of production | USA + France |
| Country of distribution | USA + France |
| Trading symbol | CLLS, ALCLS |
| Trading exchange | NASDAQ + EPA |
| Notes | (3 series funding but most updated is 2005) |
| Questions? | https://www.crunchbase.com/organization/cellectis#section-ipo-stock-price |